You are here: Industry Insights > SARS-CoV-2

News List

NIH researchers identify potential new antiviral drug for COVID-19 worldpharmanews
June 07, 2021
The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by researchers at the National Institutes of Health.
Phase II clinical trial of Niclosamide drug for treatment of COVID-19 patients begins firstwordpharma
June 07, 2021
The Council for Scientific and Industrial Research (CSIR) and Laxai Life Sciences have initiated Phase II trials of the anti-helminitic drug niclosamide for the treatment of hospitalized COVID-19 patients, reported The Economic Times.
FDA Authorizes Lower 1,200 mg Intravenous and Subcutaneous Dose of REGEN-COV™ (casirivimab and imdevimab) Antibody Cocktail to Treat Patients with COVID-19 prnewswire
June 07, 2021
EUA supported by pivotal Phase 3 data showing 1,200 mg dose reduced risk of hospitalization or death by 70%
Understanding molecular actions may be key in treating severe COVID-19 cases: Study expresspharma
June 07, 2021
In a recent study conducted at the Azrieli Faculty of Medicine of Bar-Ilan University, researchers have reported the role of several lncRNAs in anti-viral inflammatory response regulation.
Why The Relaxation In Lockdowns Is Expected To Drive The Demand For COVID-19 Diagnostics Market prnewswire
June 04, 2021
As the world has adapted to the initial phase of the global pandemic, and vaccines are being manufactured to supply the ever growing demand, tests for the virus are in great demand themselves! COVID-19 medical tests play an important role
ATS Guideline Addresses Testing for Viral Pathogens in CAP drugs
June 03, 2021
In a clinical practice guideline issued by the American Thoracic Society and published in the May 1 issue of the American Journal of Respiratory and Critical Care Medicine, nucleic acid-based viral diagnostics are suggested for hospitalized patients
Scripps Research Institute testing shows Viraleze highly active against UK COVID strain prnasia
June 02, 2021
Australia's Viraleze anti-COVID nasal spray is active against the highly infectious UK variant of SARS-CoV-2, the virus that causes COVID-19, reducing infectivity of the virus by >98%, it was announced today in a major development for the product.
U.S. Blood Supply Is Safe From Coronavirus, Study Finds drugs
June 02, 2021
COVID-19 does not pose a threat to the safety of the United States' blood supply under existing donor screening guidelines, researchers report.
Eurofins Awarded U.S. Government Agreement To Expand National COVID-19 Testing americanpharmaceuticalreview
June 02, 2021
Clinical Enterprise Inc., a Eurofins Scientific company, announced it has been awarded a U.S. Government agreement to expand national COVID-19 testing.
Scientists identify drug that prevents multiple coronavirus variants expresspharma
June 01, 2021
Scientists have identified a new drug which is highly effective in preventing severe COVID-19 in mice infected with SARS-CoV-2, and could also treat other respiratory coronaviruses.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page